Work

Clinical outcomes in advanced cervical cancer (CC) and endometrial cancer (EC) patients (pts) treated in phase I trials of novel molecularly targeted agents (MTAs).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.5596

Authors: Angela George, Vasiliki Michalarea, Saeed Rafii, Caroline O Michie, Mabel Wong, Rebecca Bowen, Liz Y. Han, Tom van Hagen, Grigorios Rallis, Udai Banerji, Rebecca Sophie Kristeleit, Johann Sebastian De Bono, Susana N. Banerjee, L Rhoda Molife, Martin Eric Gore, Stanley B. Kaye, Timothy Anthony Yap

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital, National Cancer Centre Singapore, The University of Texas MD Anderson Cancer Center, University College London

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2614735359

Cites:

Cited by:

Related to: 10